On July 14, 2026, Red White & Bloom Brands Inc. (CSE: RWB) confirmed the successful completion of its previously announced divestiture of Florida cannabis operations to M&V Investment One LLC and affiliates, alongside Royal Group Resources Ltd. This transaction is projected to remove over $123 million in consolidated liabilities from RWB's balance sheet and eliminate all future funding commitments related to its Florida business. The company will report the deconsolidation of RWB Florida, LLC and Red White & Bloom Florida Inc. in its condensed interim consolidated financial statements for the three and six months ending June 30, 2026. Moving forward, RWB plans to focus capital and management efforts on organic growth, brand licensing, and acquiring established businesses within Canada.
Key Highlights
- Red White & Bloom Brands Inc. (CSE: RWB) operates as a publicly traded multi-jurisdictional cannabis company across Canada and the U.S.
- RWB completed the sale of its Florida cannabis operations to M&V Investment One LLC and affiliates, with Royal Group Resources Ltd. involved in the transaction.
- Following deconsolidation, RWB anticipates derecognizing approximately $140.9 million in assets and $123.2 million in liabilities, recording an estimated non-cash gain near $47.7 million; the Florida segment previously incurred about $10 million in annual interest expense (FYE2025).
- RWB continues integrating the Ayurcann acquisition, including the Fuego, XPLOR, and Happy & Stoned brands, aligning with its post-divestiture growth strategy.
Completion of Florida Divestiture and Regulatory Approval
RWB announced that closing the Florida divestiture was contingent on approval from the Office of Medical Marijuana Use (OMMU), which has now been granted. The OMMU approved the change of control for the licensed RWB Florida operations, exercising its sole regulatory discretion. Licensed operations by RWB Florida continued without interruption during the regulatory review.
Management concluded that control of RWB Florida transferred to M&V effective April 1, 2026, the date M&V assumed responsibility for directing activities and funding, and became exposed to variable returns. This deconsolidation will be reflected in RWB's interim financial statements for Q2 and the first half of 2026.
Transaction Structure: Debt Acquisition and Equity Transfer
The transaction involved two main components: M&V acquired a senior secured promissory note and related security interests held by Royal Group Resources Ltd. concerning RWB Florida, along with all intercompany debt instruments issued by RWB Florida held by RWB and affiliates. Concurrently, RWB transferred its majority equity interests in RWB Florida to M&V.
The primary economic benefit to RWB was the release from liabilities and guarantees. M&V assumed all obligations underlying guarantees previously provided by RWB and its affiliates for RWB Florida. RWB and affiliates obtained full unconditional releases from these guarantees, which included indebtedness related to acquisition and funding, retail lease guarantees, and the surety bond for the Florida MMTC license.
Post-Divestiture Equity and Funding Status
RWB confirmed it holds no continuing funding obligations for RWB Florida post-transaction and will retain no equity interest in the Florida operations, marking a full operational and financial separation.
The Florida business had contributed negatively to RWB's consolidated results before the divestiture. Eliminating future funding obligations, including approximately $10 million in annual interest expense as of fiscal 2025 year-end, is a significant financial benefit noted by the company.
Accounting Impact: Asset and Liability Derecognition Under IFRS 10
Upon deconsolidation, RWB expects to derecognize about $140.9 million in assets and $123.2 million in liabilities. On the deconsolidation date, RWB Florida's net assets, including intercompany balances and intangibles, were approximately $17.7 million. RWB anticipates recording a non-cash gain of roughly $47.7 million in its consolidated operations statement for Q2 and H1 2026.
This gain reflects derecognition of a deficit attributable to RWB Florida of about $134.3 million, partially offset by derecognition of net assets (~$17.7 million), RWB's investment in Florida operations (~$55.7 million), and reclassification of cumulative foreign currency translation losses (~$13.2 million). These figures remain subject to final audit and inclusion in the 2026-Q2 interim financial statements.
Management Remarks on Financial Restructuring
Colby De Zen, RWB President, stated, "This transaction fundamentally reshapes RWB's financial profile. Eliminating an estimated $123 million in liabilities and removing ongoing funding requirements materially strengthens the company and reduces financial risk."
He added, "Our focus now is on expanding our brand portfolio, bolstered by the Fuego, XPLOR, and Happy & Stoned brands from the Ayurcann acquisition, as we pursue long-term growth. We believe we have a stronger platform, enhanced financial flexibility, and a clear path to sustained profitability and shareholder value." These comments align with the company's post-divestiture strategy.
Ayurcann Integration and Brand Expansion Strategy
RWB highlights the ongoing integration of Ayurcann, which added the Fuego, XPLOR, and Happy & Stoned cannabis brands to its portfolio, as a near-term priority following the Florida divestiture. These brands support RWB's strategy to grow organically, through brand licensing, and acquisitions of scaled businesses.
RWB identifies itself as a publicly traded multi-jurisdictional cannabis operator across Canada and the U.S., listed on the Canadian Securities Exchange under "RWB." The release does not specify revenue, store counts, or production capacity related to Ayurcann integration.
Foreign Exchange and Forward-Looking Assumptions
Financial estimates for deconsolidation are based on assumptions including a foreign exchange rate of C$1.39 per US$1.00 for translating U.S. dollar balances. All monetary amounts are in Canadian dollars unless noted. Actual results will be finalized upon completion of unaudited interim financial statements for June 30, 2026, and may vary materially.
Risks include potential auditor disagreement on accounting treatment or deconsolidation date under IFRS 10, which could alter financial presentation or impact. The final non-cash gain may differ materially from estimates. Risks also cover foreign exchange fluctuations and performance of M&V and RWB Florida under transaction terms.
Risks Related to Guarantee Releases and Transaction Completion
A key closing condition was M&V assuming all obligations underlying guarantees previously provided by RWB and its affiliates for RWB Florida. RWB secured full unconditional releases from counterparties. However, the company acknowledges risks that guarantee releases could be challenged or unenforceable, potentially exposing RWB or affiliates to residual liabilities.
Additional risks include non-payment or non-performance by M&V or RWB Florida, failure to realize expected transaction benefits, Ayurcann integration challenges, and changes in market, economic, and regulatory conditions in the Canadian cannabis sector. For detailed risk factors, readers are referred to RWB's continuous disclosure filings on SEDAR+ at www.sedarplus.ca.
Strategic Shift Toward Canadian Market Focus
The Florida divestiture marks a significant operational shift, with RWB now concentrating capital and management resources on organic growth, brand licensing, and acquiring established Canadian businesses while continuing Ayurcann integration. The release does not disclose specific acquisition targets, revenue forecasts, or timelines.
While RWB remains a multi-jurisdictional cannabis operator in Canada and the U.S., the sale removes a key U.S. operational segment. Post-divestiture, RWB's profile is increasingly focused on Canadian cannabis operations and brand-driven revenues. No specific financial guidance for the remainder of fiscal 2026 was provided.